In HDL-C measurement using precipitation or immunoassay capture, which component is targeted for removal or binding?

Prepare for the Clinical Chemistry Numericals Test. Study with comprehensive questions, each with detailed explanations. Boost your confidence and excel on your exam!

Multiple Choice

In HDL-C measurement using precipitation or immunoassay capture, which component is targeted for removal or binding?

Explanation:
HDL-C measurements rely on isolating the HDL fraction by removing all non-HDL lipoproteins. In precipitation methods, reagents cause apoB-containing lipoproteins—LDL, VLDL, IDL, and chylomicron remnants—to precipitate out, leaving HDL in the solution to be measured. In immunoassay capture approaches, strategies are used to bind or remove the particles that carry ApoB, effectively separating them from HDL so the assay signal reflects HDL cholesterol. ApoB-containing lipoproteins define the non-HDL fraction, so targeting them for removal or binding is what allows HDL-specific measurement. HDL particles themselves contain ApoA-I, not ApoB, which is why removing ApoB-containing lipoproteins is the key step.

HDL-C measurements rely on isolating the HDL fraction by removing all non-HDL lipoproteins. In precipitation methods, reagents cause apoB-containing lipoproteins—LDL, VLDL, IDL, and chylomicron remnants—to precipitate out, leaving HDL in the solution to be measured. In immunoassay capture approaches, strategies are used to bind or remove the particles that carry ApoB, effectively separating them from HDL so the assay signal reflects HDL cholesterol. ApoB-containing lipoproteins define the non-HDL fraction, so targeting them for removal or binding is what allows HDL-specific measurement. HDL particles themselves contain ApoA-I, not ApoB, which is why removing ApoB-containing lipoproteins is the key step.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy